Provided by Tiger Trade Technology Pte. Ltd.

MRBL Enhanced Equity ETF

51.80
+0.52261.02%
Volume:178
Turnover:9K
Market Cap:12.43M
PE:- -
High:51.91
Open:51.91
Low:51.80
Close:51.27
52wk High:52.39
52wk Low:42.17
Shares:240.00K
Float Shares:240.00K
Volume Ratio:0.86
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Company Profile

Company Name:
MRBL Enhanced Equity ETF
Exchange:
CBOE
Establishment Date:
2025
Employees:
- -
Office Location:
3803 West Chester Pike,Suite 150,Newtown Square,Pennsylvania,United States
Zip Code:
19073
Fax:
216 245 3686
Introduction:
Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company also develops EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding. The company was founded in 2009 and is headquartered in Berkeley Heights, New Jersey.